Teva presents interim results from PEARL study on migraine treatment - European Pharmaceutical Manufacturer
Teva Pharmaceuticals on Twitter: "Teva just announced its Q2 2022 financial results. View the press release here: https://t.co/OGECc00hWU Forward-looking statements are subject to the cautionary note included in our Q2 2022 press
Teva's shares surge as first quarter results beat expectations | The Times of Israel
Teva: ventas caen -5,6% en semestre | PharmaBiz.NET